| Document |
Document Title |
|
WO/2022/013840A1 |
Systems and methods for processing a C3 and C4 hydrocarbon mixture have been disclosed. The C3 and C4 hydrocarbon mixture is separated to remove propane from C4 hydrocarbons. The resulting C4 hydrocarbons are then processed in an isomeri...
|
|
WO/2022/013836A1 |
Systems and methods for processing a C3 and C4 hydrocarbon mixture have been disclosed. The C3 and C4 hydrocarbon mixture is first processed in an isomerization unit to isomerize n-butane to form isobutane. The resulting effluent stream ...
|
|
WO/2022/013132A1 |
The invention relates to a method for producing polyoxymethylene dimethyl ethers, having the following steps: - reacting formaldehyde and methylal (OME1) in a reactor R1, thereby obtaining a product mixture, - separating the product mixt...
|
|
WO/2022/010204A1 |
The present invention relates to a preparation method and preparation apparatus for perfluoromethylvinyl ether. The preparation method and preparation apparatus according to the present invention can prepare perfluoromethylvinyl ether ha...
|
|
WO/2022/009948A1 |
The present invention is a composition for forming a lithography film, said composition containing at least one substance which is selected from among compounds having a specific structure and resins that are obtained using the compounds...
|
|
WO/2022/009044A1 |
The invention relates to a process for preparing immediate precursors for pyroxasulfone and fenoxasulfone preparation of the formula (I). The process comprises a bromination reaction of a benzylic position without light irradiation (step...
|
|
WO/2022/004286A1 |
Provided is a manufacturing method for a polyglycerin with excellent productivity and controlled branch structures. A manufacturing method for a polyglycerin according to the present invention is characterized by reacting a (poly)glyceri...
|
|
WO/2022/003032A1 |
The present invention relates to a process for separating 1-methoxypropan-2-ol in a stream S3 from an aqueous stream comprising 1-methoxypropan-2-ol and 2-methoxypropan-1-ol, wherein the process comprises providing a stream S0 comprising...
|
|
WO/2022/004506A1 |
The present invention addresses the problem of providing a novel compound which has satisfactory solubility in solvents, has high storage stability (solution stability) during refrigeration or freeze storage, and is usable as a crosslink...
|
|
WO/2021/261062A1 |
Provided is an aqueous solution having, dissolved therein, 0.3 to 200 mM of a stilbene compound (A) that is a compound represented by formula (1) or a glycoside thereof and 0.3 to 200 mM of a flavin derivative (B) selected from riboflavi...
|
|
WO/2021/254417A1 |
Provided are a bicyclic compound as represented by formula (I), a composition and a preparation comprising the compound, a method for using the compound, and a method for preparing the compound.
|
|
WO/2021/251318A1 |
Provided is a fluorine-containing ether compound represented by the following formula. R1-R2-O-CH2-R3-CH2-O-R4-R5 (R3 is a perfluoropolyether chain; R2 is represented by formula (2), R4 is represented by formula (3), and R1 and R5 are ea...
|
|
WO/2021/251337A1 |
CB-7 exhibits a weak TLR7 inhibiting effect in normal mice. The present invention provides a novel compound with a stronger TLR7 inhibiting effect than CB-7, a pharmaceutically acceptable salt of said compound, or a prodrug of said compo...
|
|
WO/2021/250565A1 |
The present invention relates to an improved process for preparation of Empagliflozin of formula (I). The invention further relates to preparation of crystalline form of Empagliflozin and its particle size having coarser particle or D50 ...
|
|
WO/2021/251335A1 |
This fluorine-containing ether compound is represented by formula: R1-CH2-R2-CH2-OCH2CH(OH)CH2O-CH2-R3-CH2-R4 (in the formula, R2 and R3 each represent a perfluoropolyether chain, and R1 and R4 each represent a terminal group including t...
|
|
WO/2021/244894A1 |
The present invention relates to a mixture that contains at least one substituted hydroquinone monoether and at least one polymerizable compound.
|
|
WO/2021/247834A1 |
Disclosed herein are antifouling compositions and uses of antifouling compositions for controlling microbial fouling in a system in contact with an aqueous medium. The antifouling compositions comprise an antifouling compound of Formula ...
|
|
WO/2021/247832A1 |
Disclosed are oxyalkylated surfactants used in compositions and methods for inhibiting corrosion.
|
|
WO/2021/241255A1 |
Provided is a resin material that exhibits high thermal conductivity while having low relative permittivity and low dielectric loss tangent, and also has high heat resistance. A polyfunctional vinyl resin represented by general formula...
|
|
WO/2021/242971A2 |
The present disclosure provides a composition. In an embodiment, the composition includes 2-heptylundecanol; a member selected from the group consisting of 2-ethyhexanol and 2-propylheptanol; and a mixture of an alcohol (1) and an alcoho...
|
|
WO/2021/235319A1 |
A fluorine-containing ether compound according to the present invention is represented by formula (1) or formula (2). Formula (1): Q1{-(Rf12)m2-O-(Rf11O)m1-A1}n1 Formula (2): {A1-(ORf11)m1-O-(Rf12)m2-}n2Q2-[(Rf12)m2-O-(Rf11O)m1-(Rf12)m...
|
|
WO/2021/235309A1 |
Provided is a method with which it is possible to produce a corresponding ether from a carboxylic acid ester, and in which the reaction product and catalyst can be separated easily, without releasing large amounts of salt waste or harmfu...
|
|
WO/2021/236915A1 |
Provided are two-stage processes by which primary alcohols such as ethanol or 1- butanol are converted into distillate-range ethers and olefins utilizing Guerbet coupling followed by intermolecular dehydration. The ethers can be used, fo...
|
|
WO/2021/232169A1 |
The present disclosure provides a dual-drag-containing nanoparticle, in which a first antiviral drag, such as remdesivir and a second antiviral drag are co-encapsulated and co-delivered by the nanoparticle, said nanoparticle comprising a...
|
|
WO/2021/224018A1 |
The present invention describes linear compounds comprising hydrophobic tails, multiple ethoxylates and a C4-C6 end cap. The invention also relates to compositions comprising these compounds, in particular watery compositions, across a w...
|
|
WO/2021/220800A1 |
As a catalyst for realizing high palladium dispersity and a stable, electron-rich palladium site, there is provided a catalyst in which particles of an intermetallic compound of palladium and zirconium are supported on zirconium carbide ...
|
|
WO/2021/213627A1 |
The present invention relates to novel fragrance compounds of general formula (I) which exhibit a Sandalwood-like fragrance and which are derivable from campholenic aldehyde derivates according to general formula (II). Furthermore, the p...
|
|
WO/2021/204193A1 |
The present invention belongs to the field of medicaments or nutraceutical products, and specifically relates to a compound represented by the following general formula (I), or an enantiomer, diastereomer, salt, ester, prodrug, solvate, ...
|
|
WO/2021/204531A1 |
1-methoxy-2-propanol and 2-methoxy-1-propanol are recovered from an aqueous effluent stream by liquid-liquid-extraction, followed by extractive distillation, distillation of methoxypropanols from the extraction solvent and distillative s...
|
|
WO/2021/204789A2 |
The present invention relates to a process for recycling polyacetal having from 8 to 100 000 carbon atoms for obtaining a produced polyoxymethylene dialkyl ether of formula R-(OCH2)n-OR', in which R and R' independently represent a methy...
|
|
WO/2021/119397A9 |
The present invention relates to metal salts of 2-[3-[(3R)-3-[[2-chloro-3-(trifluoromethyl)phenyl]methyl-(2,
2-diphenylethyl)amino]butoxy]phenyl]acetic acid which exhibit improved physical properties and stability. The invention also rel...
|
|
WO/2021/202343A1 |
Gas separation membranes are provided and more particularly, a series of addition-type and ROMP type polynorbornenes with substituents derived from Mizoroki-Heck reactions are provided and have particular utility as gas separation membra...
|
|
WO/2021/202986A1 |
The disclosure provides therapeutic compounds, compositions (e.g., therapeutic agents or medicaments) and methods for preventing or treating mitochondrial disease such as Friedreich's ataxia in a mammalian subject, reducing risk factors,...
|
|
WO/2021/199310A1 |
The present invention is a method for producing an aromatic compound by cross-coupling reaction between a nucleophile and an electrophile, the method including a step for using Pd(OAc)2(PCy3)2 as a catalyst and causing the nucleophile an...
|
|
WO/2021/198806A1 |
Method for lowering aldehyde content in a mixture comprising (i) diethylene glycol (DEG) and/or triethylene glycol (TEG) and (ii) aldehyde are disclosed. An ion exchange resin is soaked in monoethylene glycol. The mixture comprising 5 to...
|
|
WO/2021/199003A1 |
The present invention is directed to methods of treating or preventing inflammation caused by a coronavirus infection with oxidized lipid compounds (e.g., VB-201). The present invention also directed to methods of treating or preventing ...
|
|
WO/2021/191113A1 |
The invention relates to a process for producing para-eugenol and/or ortho-eugenol comprising a step (i) of deallylation of at least one compound of formula (I): in which R1 and R2 are different, and selected from the group consisting of...
|
|
WO/2021/193952A1 |
This compound has a chain structure in which an aromatic ring group, an ether oxygen, a methylene group, an aromatic ring group, a methylene group, an ether oxygen, and an aromatic ring group are bonded in the listed order. To a carbon o...
|
|
WO/2021/187075A1 |
This polycyclic aromatic hydrocarbon compound is represented in formula (1). (In the formula, Z is a polycyclic aromatic hydrocarbon having three bonded benzene rings, L1 is an alkylene group with 1-15 carbon atoms, R1 is a hydrocarbon g...
|
|
WO/2021/186271A1 |
Described herein is a method to synthesize a perfluorinated allyl ether compound of formula (I) or a perfluorinated allyl amine compound of formula (II) Where Rf 1 and Rf 2 are (i) independently selected from a perfluorinated alkyl group...
|
|
WO/2021/182438A1 |
The purpose of the present invention is to provide a composition containing a borate compound which is useful as a cocatalyst for the solution polymerization of olefin or diene and is soluble in a hydrocarbon solvent. According to the ...
|
|
WO/2021/177287A1 |
The present invention addresses the problem of providing a catalyst which exhibits high reusability and is capable of reducing the amount of residual metals in a reaction liquid in a process wherein an optically active reduction product ...
|
|
WO/2021/177290A1 |
A method for producing a mono-cross-coupled aromatic compound (3-1), said method comprising: preparation of an aromatic compound (1) that has at least two leaving groups; preparation of a compound (2) that is capable of undergoing a cros...
|
|
WO/2021/177000A1 |
A method for producing a fluorine-containing olefin by causing a reaction between a second olefin and a first olefin represented by formula (1) in the presence of a ruthenium compound represented by formula (X).
|
|
WO/2021/170864A1 |
The present invention is directed to a process for the manufacture of 1,1,4,4- tetramethoxy-2-butene from 2,5-dimethoxy-2,5-dihydrofuran with methanol in the presence of an acidic ion exchanger as catalyst, whereby the molar ratio of 2,5...
|
|
WO/2021/160139A1 |
A 9,10-dihydrophenanthrene compound and use thereof in the treatment of liver injury. Specifically, a compound of formula (I) or a compound of formula (II) is provided, which exhibits anti-inflammatory and antioxidant activities in liver...
|
|
WO/2021/161807A1 |
The present invention provides an efficient production method for obtaining reduced coenzyme Q10 crystals of Form II that is a stable crystalline form. The production method of the present invention comprises a step for adding a Form I...
|
|
WO/2021/160920A1 |
Dendrimer-based nanostructures for the diagnosis of allergies to beta-lactam antibiotics and applications. The structure has the formula B-D-L-H-L-D-B, where: H is a hydrophilic polymer (PEG), L is a linker (maleimide), D is a dendrimer ...
|
|
WO/2021/157563A1 |
A fluorine-containing ether compound that is characterized by being represented by the following formula (1). Formula (1): R1-(O(CH2)a)b-[A]-[B]-O-CH2-R2-CH2-R3 (In formula (1), R1 is an alkyl group that may have a substituent group, o...
|
|
WO/2021/151871A1 |
The invention relates to a method for producing oxymethylene ether of the general formula CH3O-(CH2O)m-CH3 in a liquid phase process, wherein 1 ≤ m ≤ 10. In a catalytic reaction, molecular oxygen or an oxygen-containing oxidizing age...
|
